Rebiopsy in Advanced NSCLC: Clinical Relevance and Prognostic Implications
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
Lung Cancer 2022 Apr 16;168(xx)10-20, M Scheffler, M Wiesweg, S Michels, L Nogová, A Kron, T Herold, AH Scheel, M Metzenmacher, WE Eberhardt, H Reis, J Fassunke, K Darwiche, C Aigner, D Schaufler, R Riedel, R Fischer, S Koleczko, HU Schildhaus, S Merkelbach-Bruse, KW Schmid, R Büttner, J Wolf, M SchulerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.